Furthermore, analysis of mammary gland and tumors from VDRKO mice demonstrated that loss of VDR was associated with enhanced HAS2 and HA accumulation in vivo.(22) Thus, vitamin D signaling directly compromises breast cancer stem cell viability and potentially delays tumor progression via interruption of HA‐CD44 survival signaling in the TME. This evidence concerns the gene HAS2 and breast cancer.